DNA ÇÕ¼º ½ÃÀå ±Ô¸ð, Á¡À¯À², µ¿Ç⠺м® ¸®Æ÷Æ® : ¼­ºñ½º À¯Çüº°, ±æÀ̺°, ¿ëµµº°, ÃÖÁ¾ ¿ëµµº°, Áö¿ªº°, ºÎ¹®º° ¿¹Ãø(2024-2030³â)
DNA Synthesis Market Size, Share & Trends Analysis Report By Service Type (Gene Synthesis, Oligonucleotide Synthesis), By Length, By Application (Research Development, Diagnostics), By End-use, By Region, And Segment Forecasts, 2024 - 2030
»óǰÄÚµå : 1511798
¸®¼­Ä¡»ç : Grand View Research, Inc.
¹ßÇàÀÏ : 2024³â 06¿ù
ÆäÀÌÁö Á¤º¸ : ¿µ¹® 120 Pages
 ¶óÀ̼±½º & °¡°Ý (ºÎ°¡¼¼ º°µµ)
US $ 5,950 £Ü 8,443,000
Unprintable PDF & Excel (Single User License) help
º¸°í¼­ PDF ¹× ¿¢¼¿À» 1Àθ¸ »ç¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. ÅØ½ºÆ® µîÀÇ º¹»ç ¹× ºÙ¿©³Ö±â, Àμâ´Â ºÒ°¡´ÉÇÕ´Ï´Ù.
US $ 6,950 £Ü 9,862,000
Printable PDF & Excel (5-User License) help
º¸°í¼­ PDF ¹× ¿¢¼¿À» µ¿ÀÏ ±â¾÷ ³» µ¿ÀÏ ºÎ¼­¿¡¼­ ÃÖ´ë 5¸í±îÁö »ç¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. ÅØ½ºÆ® µîÀÇ º¹»ç ¹× ºÙ¿©³Ö±â, Àμâ´Â °¡´ÉÇÕ´Ï´Ù.
US $ 8,950 £Ü 12,700,000
Printable PDF & Excel (Enterprise License) help
º¸°í¼­ ±¸¸Å ±â¾÷ ¹× ±× ÀÚȸ»ç, °ü°è»ç°¡ »ç¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀ̸ç, PDF ¹× ¿¢¼¿ ÅØ½ºÆ® µîÀÇ º¹»ç ¹× ºÙ¿©³Ö±â, ÀμⰡ °¡´ÉÇÕ´Ï´Ù.


¤± Add-on °¡´É: °í°´ÀÇ ¿äû¿¡ µû¶ó ÀÏÁ¤ÇÑ ¹üÀ§ ³»¿¡¼­ CustomizationÀÌ °¡´ÉÇÕ´Ï´Ù. ÀÚ¼¼ÇÑ »çÇ×Àº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.

Çѱ۸ñÂ÷

DNA ÇÕ¼º ½ÃÀåÀÇ ¼ºÀå°ú µ¿Çâ :

Grand View Research, Inc.ÀÇ ÃֽЏ®Æ÷Æ®¿¡ µû¸£¸é ¼¼°èÀÇ DNA ÇÕ¼º ½ÃÀå ±Ô¸ð´Â 2030³â±îÁö 82¾ï 6,000¸¸ ´Þ·¯¿¡ ´ÞÇÒ Àü¸ÁÀÔ´Ï´Ù.

ÀÌ ½ÃÀåÀº ȯÀÚ Ä¡·á¸¦ °áÁ¤ÇÏ´Â µ¥ µµ¿òÀÌ µÇ´Â °³ÀÎ ¸ÂÃãÇü À¯Àüü ½ÃÄö½Ì¿¡ ´ëÇÑ °ü½ÉÀÌ ³ô¾ÆÁö¸é¼­ 2024-2030³â 15.30%ÀÇ ¿¬Æò±Õ º¹ÇÕ ¼ºÀå·ü(CAGR)À» ³ªÅ¸³¾ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ¶ÇÇÑ DNA ÇÕ¼ºÀº Áúº´ ¸ð´ÏÅ͸µ, ½Å¾à °³¹ß ¹× ¾à¹°À¯ÀüüÇп¡ ±¤¹üÀ§ÇÏ°Ô Àû¿ëµÉ ¼ö ÀÖ´Â »ý¹°ÇÐÀû ¿¬±¸ Ȱµ¿¿¡ Çõ¸íÀ» ÀÏÀ¸Å³ ¼ö ÀÖ´Â ´É·ÂÀ» °¡Áö°í ÀÖ½À´Ï´Ù.

COVID-19 ÆÒµ¥¹ÍÀº COVID-19 °¨¿°°ú ´Ù¾çÇÑ À¯ÇüÀÇ ¾Ï Ä¡·á¸¦ À§ÇÑ mRNA ±â¹Ý ¹é½ÅÀÇ Ã¤Åÿ¡ ±àÁ¤ÀûÀÎ ¿µÇâÀ» ¹ÌÃÆÀ¸¸ç, mRNAÀÇ À¯¿ë¼ºÀº ÇÕ¼º DNA¿¡ ´ëÇÑ ¼ö¿ä¸¦ Áõ°¡½ÃÄ×½À´Ï´Ù. ¶ÇÇÑ COVID-19 ¿¬±¸ÀÇ ÁÖ¿ä ÃÊÁ¡Àº DNA ÇÕ¼º¿¡ ÀÖ½À´Ï´Ù. ÇÕ¼º DNA´Â ¸ðµç PCR ºÐ¼®¿¡ »ç¿ëµË´Ï´Ù. ȯÀÚ´Â »ùÇÿ¡ Á¸ÀçÇÒ ¼ö ÀÖ´Â À¯Àüü DNA¸¦ ½Äº°Çϱâ À§ÇØ DNA ÇÁ¶óÀ̸Ӹ¦ »ç¿ëÇØ¾ß ÇÕ´Ï´Ù.

È¿¼Ò °øÇÐÀÇ ¹ßÀüÀº È¿¼Ò DNA ÇÕ¼ºÀ» À§ÇÑ ´Ù¾çÇÑ Á¢±Ù¹ýÀÇ °³¹ßÀ» ÃËÁøÇϰí ÀÖ½À´Ï´Ù. È¿¼Ò¸¦ »ç¿ëÇÏ¿© ÇÙ»êÀ» ÇÊ¿äÇÑ ¼ø¼­·Î ¿¬¼âÇÏ´Â °ÍÀ¸·Î, ³Î¸® Àû¿ëÇϱâ À§Çؼ­´Â ´õ ¸¹Àº ÃÖÀûÈ­°¡ ÇÊ¿äÇÕ´Ï´Ù. ¸¹Àº ½ÃÀå °ü°èÀÚµéÀÌ ÂªÀº ½Ã°£¿¡ È¿À²ÀûÀ¸·Î È¿¼Ò¸¦ »ý»êÇÒ ¼ö ÀÖ´Â »õ·Î¿î ±â¼úÀ» °³¹ßÇϱâ À§ÇØ ³ë·ÂÇϰí ÀÖ½À´Ï´Ù. ¿¹¸¦ µé¾î 2021³â 5¿ù Ribbon Biolabs´Â 10,000 ¿°±â½ÖÀÇ DNA ¼­¿­À» ÇÕ¼ºÇÏ´Â ÀÓ¹«¸¦ ¼³Á¤Çϰí 2021³â 12¿ù±îÁö 20,000 ¿°±â½ÖÀÇ DNA ºÐÀÚ¸¦ ÇÕ¼ºÇÏ´Â ÀÌÁ¤Ç¥¸¦ ´Þ¼ºÇß½À´Ï´Ù.

À¯ÀüÀÚ ÇÕ¼ºÀº ƯÁ¤ ´ºÅ¬·¹¿ÀƼµå ¼­¿­¿¡ ÀÇÇÑ Ç¥Àû µ¹¿¬º¯ÀÌ À¯µµ ¹× ¿øÇϴ ǥÇöÇü ¹ßÇöÀ» Á¶ÀýÇÏ´Â µî ´Ù¾çÇÑ ¿ëµµ·Î »ç¿ëµË´Ï´Ù. À¯ÀüÀÚ ÇÕ¼ºÀº À¯Àü°øÇÐÀÇ ÁÖ¿ä ±âÃʸ¦ Çü¼ºÇϰí, ³ôÀº ƯÀ̼ºÀ» °¡Áø Ç×ü ´ÜÆíÀÇ °³¹ß·Î Ç×üÀÇ ¹üÀ§¿Í ǰÁúÀ» Å©°Ô Çâ»ó½ÃÄ×½À´Ï´Ù.

¿Ã¸®°í´ºÅ¬·¹¿ÀŸÀ̵å ÇÕ¼ºÀº ÇÊ¿äÇÑ °áÁ¤ÀûÀÎ ¼­¿­À» °¡Áø ºñ±³Àû ªÀº ÇÙ»ê Á¶°¢À» ½ÇÇè½Ç¿¡¼­ »ý»êÇÏ´Â °ÍÀÔ´Ï´Ù. ÀÌ ±â¼úÀº ¿øÇÏ´Â ¿°±â¼­¿­ÀÇ ¸ÂÃãÇü ¿Ã¸®°í´ºÅ¬·¹¿ÀƼµå¸¦ ºü¸£°í Àú·ÅÇÏ°Ô ¾òÀ» ¼ö ÀÖ´Â ¸Å¿ì °­·ÂÇÑ ¹æ¹ýÀÔ´Ï´Ù. °¢ ±â¾÷Àº ´ºÅ¬·¹¿ÀƼµå ÇÕ¼º °úÁ¤À» Áö¿øÇϱâ À§ÇØ ¿Ã¸®°í´ºÅ¬·¹¿ÀƼµå ¶óÀ̺귯¸®¸¦ °í¾ÈÇØ³Â½À´Ï´Ù. ¿¹¸¦ µé¾î 2022³â 7¿ù Ribbon Biolabs´Â ´Ù¾çÇÑ ¿Ã¸®°í´ºÅ¬·¹¿ÀƼµå ¶óÀ̺귯¸®¸¦ »ç¿ëÇÏ¿© ´ºÅ¬·¹¿ÀƼµå ºÐÀÚ¸¦ ÇÕ¼ºÇÏ´Â Ribbon BiolabsÀÇ ¹æ¹ý¿¡ ´ëÇÑ ¹Ì±¹ ƯÇ㸦 ÃëµæÇß´Ù°í ¹ßÇ¥Çß½À´Ï´Ù. ÀÌ ¹æ¹ýÀº ¹Ì¸® ±¸ÃàµÈ ¿Ã¸®°í´ºÅ¬·¹¿ÀŸÀÌµå ¶óÀ̺귯¸®·Î ±¸¼ºµÇ¾î ÀÖÀ¸¸ç, È¿À²ÀûÀÎ Á¢±ÙÀÌ °¡´ÉÇÕ´Ï´Ù.

DNA ÇÕ¼º ½ÃÀå º¸°í¼­ÀÇ ÇÏÀ̶óÀÌÆ®

¸ñÂ÷

Á¦1Àå Á¶»ç ¹æ¹ý°ú ¹üÀ§

Á¦2Àå ÁÖ¿ä ¿ä¾à

Á¦3Àå DNA ÇÕ¼º ½ÃÀå º¯¼ö, µ¿Çâ, ¹üÀ§

Á¦4Àå DNA ÇÕ¼º ½ÃÀå : ¼­ºñ½º À¯Çü ÃßÁ¤¡¤µ¿Ç⠺м®

Á¦5Àå DNA ÇÕ¼º ½ÃÀå : ±æÀÌ ÃßÁ¤¡¤µ¿Ç⠺м®

Á¦6Àå DNA ÇÕ¼º ½ÃÀå : ¿ëµµ ÃßÁ¤¡¤µ¿Ç⠺м®

Á¦7Àå DNA ÇÕ¼º ½ÃÀå : ÃÖÁ¾ ¿ëµµ ÃßÁ¤¡¤µ¿Ç⠺м®

Á¦8Àå DNA ÇÕ¼º ½ÃÀå : Áö¿ª ÃßÁ¤¡¤µ¿Ç⠺м®

Á¦9Àå °æÀï ±¸µµ

KSA
¿µ¹® ¸ñÂ÷

¿µ¹®¸ñÂ÷

DNA Synthesis Market Growth & Trends:

The global DNA synthesis market size is expected to reach USD 8.26 billion by 2030, according to a new report by Grand View Research, Inc. The market is expected to register a CAGR of 15.30% from 2024 to 2030 owing to the rising focus on personalized genome sequencing that aids determine patient care. In addition, DNA synthesis has the capability to revolutionize biological research activities for widespread applications in disease monitoring, drug discovery, and pharmacogenomics.

The COVID-19 pandemic positively impacted the adoption of mRNA-based vaccines for the treatment of COVID-19 infection and different types of cancers. The utility of mRNA boosts the demand for synthetic DNA. Furthermore, a major focus of Covid-19 research is DNA synthesis. Synthetic DNA is used in all PCR analyses. Patients need to use a DNA primer to identify any genomic DNA that may be present in the sample.

Progress in enzyme engineering is boosting the development of different approaches for enzymatic DNA synthesis. It involves the use of enzymes to chain the nucleic acids together in the required sequence and requires further optimization for its widespread applications. Many market players are striving to devise novel technologies for efficient enzymatic production of nucleotides in the lowest turnaround time. For instance, in May 2021, Ribbon Biolabs set a mission of synthesizing DNA sequences of 10,000 base pairs and accomplished a milestone of a 20,000 base pair DNA molecule by December 2021.

Gene synthesis has a broad spectrum of applications in targeted mutagenesis with a specific sequence of nucleotides along with the regulation of a desired phenotypic expression. It forms the primary basis of genetic engineering, which has significantly leveraged the scope and quality of antibodies by the development of antibody fragments with high specificity.

Oligonucleotide synthesis is the laboratory-based production of relatively short fragments of nucleic acids in a required definitive sequence. The technique is an extremely robust practice that facilitates rapid and inexpensive access to the custom-made oligonucleotides of the desired sequence. Companies have devised their oligonucleotide libraries to aid their nucleotide synthesis processes. For instance, in July 2022, Ribbon Biolabs declared that it secured a U.S. Patent that comprises Ribbon Biolabs' method for the synthesis of a nucleotide molecule using a diverse library of oligonucleotides. The approach comprises a pre-built library of oligonucleotides for efficient access.

DNA Synthesis Market Report Highlights:

Table of Contents

Chapter 1. Methodology and Scope

Chapter 2. Executive Summary

Chapter 3. DNA Synthesis Market Variables, Trends & Scope

Chapter 4. DNA Synthesis Market: Service Type Estimates & Trend Analysis

Chapter 5. DNA Synthesis Market: Length Estimates & Trend Analysis

Chapter 6. DNA Synthesis Market: Application Estimates & Trend Analysis

Chapter 7. DNA Synthesis Market: End-Use Estimates & Trend Analysis

Chapter 8. DNA Synthesis Market: Regional Estimates & Trend Analysis

Chapter 9. Competitive Landscape

(ÁÖ)±Û·Î¹úÀÎÆ÷¸ÞÀÌ¼Ç 02-2025-2992 kr-info@giikorea.co.kr
¨Ï Copyright Global Information, Inc. All rights reserved.
PC¹öÀü º¸±â